Autologous bone marrow mononuclear cell transplantation
NGBSI-03
Phase 2 mab terminated
Quick answer
Autologous bone marrow mononuclear cell transplantation for Spinal Cord Injury is a Phase 2 program (mab) at EuroGen Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- EuroGen Pharmaceuticals Ltd
- Indication
- Spinal Cord Injury
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated